This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

Vaccination is an important strategy for preventing infections in patients with hematologic malignancies. Hematopoietic cell transplant (HCT) recipients have diminished immunity against vaccine-preventable diseases after transplantation.

The second part of the 2012 NCCN Case Manager and Medical Director Program™ webinar series is on the topics of metastatic melanoma, acute myeloid leukemia, cancer survivorship, and techniques for telephonic case managers.

This information was originally presented on March 17, 2012, at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.
 

The 2012 NCCN Case Manager and Medical Director Program will include various educational platforms, including but not limited to, four webinars on the topics of Lung Cancer, Non-Hodgkin’s Lymphoma, Gynecologic Malignancies, and Communicating with Patients As Goals Change.

This information was originally presented on March 17, 2012, at the NCCN 17th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ held in Hollywood, Florida.